Brief: Haemonetics Q3 Earnings Per Share $0.45
Feb 8 (Reuters) - Haemonetics Corp HAE.N :
* Q3 EARNINGS PER SHARE $0.45
* Q3 ADJUSTED EARNINGS PER SHARE $0.84
* QTRLY REVENUE INCREASE 8% TO $260 MILLION
* UPDATED ITS PREVIOUS FISCAL 2022 GAAP TOTAL REVENUE GROWTH
GUIDANCE FROM 13 – 17% TO 12 – 14%
* SEES 2022 ADJUSTED EPS $2.45 - $2.55
* Q3 EARNINGS PER SHARE VIEW $0.73, REVENUE VIEW $266.7
MILLION --
REFINITIV IBES DATA
* FY2022 EARNINGS PER SHARE VIEW $2.53 -- REFINITIV IBES
DATA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices